#427: Medical Device Reimbursement - Pitfalls to Avoid

Global Medical Device Podcast · 6 Oct 2025 · 41m · Episode 427

AI in practice: one real use of AI described

What this episode covers

Haley King, co-founder and CEO of Paxos Health, explains the critical distinction between FDA approval and securing reimbursement, detailing the three pillars of coding, coverage, and payment. She highlights the challenge of navigating CPT codes, specifically the gap between temporary Category 3 codes and the gold-standard Category 1, and notes that securing Medicare coverage can take an average of 5.7 years for innovative devices. King discusses how AI tools are being used to streamline manual patient access tasks, such as prior authorizations and appeals, while emphasizing the necessity of keeping human experts in the loop for high-stakes decisions. The conversation covers the importance of designing clinical trials with payer requirements in mind to avoid costly delays and ensure commercial success.

AI in practice

Where this conversation describes AI being used to build or deliver a product. Part of the AI in practice tracker.

Marketing & salesPaxos Health (proprietary AI tool)

The AI tool automates the review of payer policies and patient clinical records to generate customized prior authorization arguments, reducing manual document review time and improving submission quality.

“we've built a tool that uses AI to try to eliminate those cumbersome tasks that … going through 100s of pages of medical documents … we automate that, but we set the interface up in a way so that the user has full visibility…”

Speaker 3 · Hear it at 24:55

Mentioned

Companies
Paxos Health, Medtronic, Cooler Heads Care, United Healthcare, Aetna
Also
CMS, Epic, Athena, ChatGPT, FDA, AMA

Other shows on the same ground, closest first.

  • The Builder Circle · 1h 11m

    S2 E2: Demystifying Medical Device and System Development with Alan Cohen

    Alan Cohen, author of 'Prototype to Product' and a systems engineering manager specializing in radiation therapy devices, explains the complexities of medical device development to host Sera Evcimen. Cohen emphasizes that successful startups often emerge from collaborations between engineers and clinicians, and he details the critical importance of understanding reimbursement models, specifically CPT codes, before building a product. He advocates for using Fault Tree Analysis over FMEA for complex systems to manage risk efficiently and advises founders to balance lean documentation with rigorous process adherence to satisfy FDA requirements without over-engineering.

  • Let's Combinate · 59m

    027 - "Become a Historian of the Problem" with Duane Mancini

    Duane Mancini, CEO and Managing Partner of Project Medtech, discusses his transition from medicinal chemistry to medical device regulatory strategy at NAMSA and LabCorp. He explains the critical importance of integrating reimbursement strategy early in the development of combination products to avoid commercialization failures, noting that regulatory choices like 510(k) can negatively impact reimbursement pathways. Mancini details how Project Medtech supports startups through its podcasts, Startup Symposiums, and consulting services, focusing on capital raising, milestone mapping, and navigating the complexities of drug-device combinations like insulin patches.

  • Being an Engineer · 51m

    S6E19 Stuart Grant | MedTech Innovation

    Dr. Stuart Grant, founder of Archetype MedTech, discusses his 25-year career at Johnson & Johnson and DePuy Synthes before launching his consultancy to help startups navigate medical device development. He details the challenges of securing funding, managing regulatory differences between the EU's MDR and the US FDA, and the strategic importance of narrow clinical indications. Grant also explores future trends in surgical robotics and AI, emphasizing the need for modular platforms and the value of accumulated engineering knowledge.

  • Let's Combinate · 26m

    176 - The Fastest Way to Ruin Drug/Device Development (And How to Avoid It!) with Eric Sugalski

    Eric Sugalski, founder and CTO of Archimedic, explains that the fastest way to ruin drug-device development is premature concept lock and misaligned outsourcing strategies. He argues that companies must distinguish between needing overflow capacity versus specialized expertise, such as human factors or industrial design, to avoid the 'piecemeal approach' that destroys innovation. Sugalski emphasizes the importance of early, hands-on user research and open-source quality management systems to bridge the gap between engineering and clinical reality, warning that locking down requirements before validating use cases injects costly redo loops into the project.

  • Product Startup · 23m

    104: Medical Device Certification vs Wellness Device

    Bryon Bhagwandin, a medical device entrepreneur with a PhD from the University of Washington, explains the critical differences between wellness and medical devices, emphasizing that medical clearance allows sales into clinical settings. He details the three pillars of medical certification: safety, efficacy (verification and validation), and manufacturing consistency, noting that hand-built prototypes cannot be certified without statistical proof of uniform production. Bhagwandin advises that while wellness devices are cheaper to launch, starting with a medical device strategy is often superior because it opens higher-margin B2B channels and allows for easier transition to consumer markets. He also suggests that founders can leverage user data from existing wellness products to support the regulatory submission of a redesigned medical version, provided they maintain rigorous quality and avoid feature creep.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Global Medical Device Podcast. The episode itself belongs to its publisher.